Receptor research on xenohormone effects of human serum extracts containing the actual mixture of perfluorinated alkyl acids: a short review

Christian Bjerregaard-Olesen, Eva Cecilie Bonefeld-Jørgensen

Abstract


Perfluorinated alkyl acids (PFAAs) are used in many household products including food contact materials. Hence, humans are continuously exposed, and the PFAAs are accumulated in human serum with half-lives up to 8.8 years. In humans, high PFAA serum levels have been associated with an increased risk of breast cancer and other adverse health effects such as lower birth weight and longer time to pregnancy which might be related to disruptions of various hormonal systems. For instance, direct cell exposure studies in vitro suggest that some PFAAs can transactivate the estrogen receptor (ER), antagonize the androgen receptor (AR) and has the potential to interfere with TH and AhR functions. Moreover, the PFAAs also showed cellular oxidative stress.

Humans are exposed to an array of PFAAs, and the quantity and combination of these PFAAs in human serum differs between individuals. Hence, the toxicological studies of single PFAAs and simple mixtures might be insufficient to predict how the actual mixtures of PFAAs may affect humans. To get a better evaluation of the actual mixture effects, we developed a method to extract the actual mixture of PFAAs from human serum. Preliminary results showed that 17% of the PFAA serum fractions from pregnant women could significantly transactivate the ER, and 94% of the fractions could further increase the transactivity induced by the potent ER ligand 25 pM 17β-estradiol. As part of the international FETOTOX project (http://fetotox.au.dk/), we are currently extracting the actual PFAA serum mixture from 700 pregnant women to further elucidate whether the serum PFAA mixture can transactivate the ER at the levels found in human serum. We suggest that our method can in the future be used to study the actual serum PFAA mixture effects on both steroid hormone actions as well as other hormonal systems e.g. thyroid hormone function. In the current review we will discuss how our recently developed PFAA extraction method might be used in future research to assess the endocrine impact of PFAAs on human health.


Full Text:

PDF

References


Prevedouros K, Cousins IT, Buck RC, Korzeniowski SH. Sources, fate and transport of perfluorocarboxylates. Environ Sci Technol 2006; 40: 32-44.

Long-Chain Perfluorinated Chemicals (PFCs) - Action Plan, U.S. EPA, [http://www.epa.gov/oppt/existingchemicals/pubs/pfcs_action_plan1230_09.pdf], 2009.

Rayne S, Forest K. Perfluoroalkyl sulfonic and carboxylic acids: A critical review of physicochemical properties, levels and patterns in waters and wastewaters, and treatment methods. J Environ Sci Health A Tox Hazard Subst Environ Eng 2009; 44: 1145-1199.

Posner S, Ross S, Poulsen PB, Jörundsdottir HÓ, Gunnlaugsdóttir H, Trier X, et al., Per- and polyfluorinated substances in the Nordic Countries - Use, occurence and toxicology. 2013, Norden: http://dx.doi.org/10.6027/TN2013-542 p. 1-231.

Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL, et al. Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect 2007; 115: 1298-1305.

Kim S, Choi K, Ji K, Seo J, Kho Y, Park J, et al. Trans-Placental Transfer of Thirteen Perfluorinated Compounds and Relations with Fetal Thyroid Hormones. Environ Sci Technol 2011; 45: 7465-7472.

Needham LL, Grandjean P, Heinzow B, Jorgensen PJ, Nielsen F, Patterson DG, Jr., et al. Partition of environmental chemicals between maternal and fetal blood and tissues. Environ Sci Technol 2011; 45: 1121-1126.

Bach CC, Bech BH, Brix N, Nohr EA, Bonde JP, Henriksen TB. Perfluoroalkyl and polyfluoroalkyl substances and human fetal growth: A systematic review. Crit Rev Toxicol 2014: 1-15.

Fei C, McLaughlin JK, Tarone RE, Olsen J. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect 2007; 115: 1677-1682.

Maisonet M, Terrell ML, McGeehin MA, Christensen KY, Holmes A, Calafat AM, et al. Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in British girls. Environ Health Perspect 2012; 120: 1432-1437.

Halldorsson TI, Rytter D, Haug LS, Bech BH, Danielsen I, Becher G, et al. Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study. Environ Health Perspect 2012; 120: 668-673.

Vested A, Ramlau-Hansen CH, Olsen SF, Bonde JP, Kristensen SL, Halldorsson TI, et al. Associations of in Utero Exposure to Perfluorinated Alkyl Acids with Human Semen Quality and Reproductive Hormones in Adult Men. Environ Health Perspect 2013; 121: 453-458.

Lopez-Espinosa MJ, Fletcher T, Armstrong B, Genser B, Dhatariya K, Mondal D, et al. Association of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) with age of puberty among children living near a chemical plant. Environ Sci Technol 2011; 45: 8160-8166.

Lyngso J, Ramlau-Hansen CH, Hoyer BB, Stovring H, Bonde JP, Jonsson BA, et al. Menstrual cycle characteristics in fertile women from Greenland, Poland and Ukraine exposed to perfluorinated chemicals: a cross-sectional study. Hum Reprod 2014; 29: 359-367.

Fei C, McLaughlin JK, Lipworth L, Olsen J. Maternal levels of perfluorinated chemicals and subfecundity. Hum Reprod 2009; 24: 1200-1205.

Bonefeld-Jorgensen EC, Long M, Bossi R, Ayotte P, Asmund G, Kruger T, et al. Perfluorinated compounds are related to breast cancer risk in Greenlandic Inuit: a case control study. Environ Health 2011; 10: 88.

Bonefeld-Jorgensen EC, Long M, Fredslund SO, Bossi R, Olsen J. Breast cancer risk after exposure to perfluorinated compounds in Danish women: a case-control study nested in the Danish National Birth Cohort. Cancer Causes Control 2014; 25: 1439-1448.

Land M, De Wit CA, Cousins IT, Herzke D, Johansson J, Martin JW. What is the effect of phasing out long-chain per- and polyfluoroalkyl substances on the concentrations of perfluroalkyl acids and their precursors in the environment? A systematic review protocol. Environmental Evidence 2015; 4: 3.

Kato K, Wong LY, Jia LT, Kuklenyik Z, Calafat AM. Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999-2008. Environ Sci Technol 2011; 45: 8037-8045.

Olsen GW, Lange CC, Ellefson ME, Mair DC, Church TR, Goldberg CL, et al. Temporal trends of perfluoroalkyl concentrations in American Red Cross adult blood donors, 2000-2010. Environ Sci Technol 2012; 46: 6330-6338.

Schroter-Kermani C, Muller J, Jurling H, Conrad A, Schulte C. Retrospective monitoring of perfluorocarboxylates and perfluorosulfonates in human plasma archived by the German Environmental Specimen Bank. Int J Hyg Environ Health 2013; 216: 633-640.

Long M, Bossi R, Bonefeld-Jorgensen EC. Level and temporal trend of perfluoroalkyl acids in Greenlandic Inuit. Int J Circumpolar Health 2012; 71.

Jin Y, Saito N, Harada KH, Inoue K, Koizumi A. Historical trends in human serum levels of perfluorooctanoate and perfluorooctane sulfonate in Shenyang, China. Tohoku J Exp Med 2007; 212: 63-70.

Rusyn Il, Fritschi L, Sergi CM, Hansen J, Le Curieux F, Bolt HM, et al. Carcinogenicity of perfluorooctanoic acid, tetrafluoroethylene, dichloromethane, 1,2-dichloropropane and 1,3-propane solution. Lancet Oncol 2014; 15: 924-925.

Wielsoe M, Long M, Ghisari M, Bonefeld-Jorgensen EC. Perfluoroalkylated substances (PFAS) affect oxidative stress biomarkers in vitro. Chemosphere 2014; In press.

Ghisari M, Eiberg H, Long M, Bonefeld-Jorgensen EC. Polymorphisms in phase I and phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case-control study in Inuit women. Environ Health 2014; 13: 19.

Kjeldsen LS, Bonefeld-Jorgensen EC. Perfluorinated compounds affect the function of sex hormone receptors. Environ Sci Pollut Res 2013; 20: 8031-8044.

Kortenkamp A. Ten years of mixing cocktails: a review of combination effects of endocrine-disrupting chemicals. Environ Health Perspect 2007; 115 Suppl 1: 98-105.

Bonefeld-Jorgensen EC, Ghisari M, Wielsoe M, Bjerregaard-Olesen C, Kjeldsen LS, Long M. Biomonitoring and hormone-disrupting effect biomarkers of persistent organic pollutants in vitro and ex vivo. Basic Clin Pharmacol Toxicol 2014; 115: 118-128.

Hjelmborg PS, Ghisari M, Bonefeld-Jorgensen EC. SPE-HPLC purification of endocrine-disrupting compounds from human serum for assessment of xenoestrogenic activity. Anal Bioanal Chem 2006; 385: 875-887.

Kruger T, Ghisari M, Hjelmborg PS, Deutch B, Bonefeld-Jorgensen EC. Xenohormone transactivities are inversely associated to serum POPs in Inuit. Environ Health 2008; 7: 38.

Kruger T, Hjelmborg PS, Jonsson BA, Hagmar L, Giwercman A, Manicardi GC, et al. Xenoandrogenic activity in serum differs across European and Inuit populations. Environ Health Perspect 2007; 115 Suppl 1: 21-27.

Kruger T, Long M, Ghisari M, Bonefeld-Jorgensen EC. The combined effect of persistent organic pollutants in the serum POP mixture in Greenlandic Inuit: xenoestrogenic, xenoandrogenic and dioxin-like transactivities. Biomarkers 2012; 17: 692-705.

Kruger T, Spano M, Long M, Eleuteri P, Rescia M, Hjelmborg PS, et al. Xenobiotic activity in serum and sperm chromatin integrity in European and inuit populations. Mol Reprod Dev 2008; 75: 669-680.

Bonefeld-Jorgensen EC, Hjelmborg PS, Reinert TS, Andersen BS, Lesovoy V, Lindh CH, et al. Xenoestrogenic activity in blood of European and Inuit populations. Environ Health 2006; 5: 12.

Long M, Stronati A, Bizzaro D, Kruger T, Manicardi GC, Hjelmborg PS, et al. Relation between serum xenobiotic-induced receptor activities and sperm DNA damage and sperm apoptotic markers in European and Inuit populations. Reproduction 2007; 133: 517-530.

Bjerregaard-Olesen C, Bossi R, Bech BH, Bonefeld-Jorgensen EC. Extraction of perfluorinated alkyl acids from human serum for determination of the combined xenoestrogenic transactivity: A method development. Chemosphere 2014; In press.

Bonefeld-Jorgensen EC. Biomonitoring in Greenland: human biomarkers of exposure and effects - a short review. Rural Remote Health 2010; 10: 1362.

Long M, Ghisari M, Bonefeld-Jorgensen EC. Effects of perfluoroalkyl acids on the function of the thyroid hormone and the aryl hydrocarbon receptor. Environ Sci Pollut Res Int 2013; 20: 8045-8056.

Melzer D, Rice N, Depledge MH, Henley WE, Galloway TS. Association between Serum Perfluorooctanoic Acid (PFOA) and Thyroid Disease in the US National Health and Nutrition Examination Survey. Environ Health Perspect 2010; 118: 686-692.

Sinjari T, Darnerud PO. Hydroxylated polychlorinated biphenyls: placental transfer and effects on thyroxine in the foetal mouse. Xenobiotica 1998; 28: 21-30.

Meerts IA, Assink Y, Cenijn PH, Van Den Berg JH, Weijers BM, Bergman A, et al. Placental transfer of a hydroxylated polychlorinated biphenyl and effects on fetal and maternal thyroid hormone homeostasis in the rat. Toxicol Sci 2002; 68: 361-371.

Dallaire R, Dewailly E, Pereg D, Dery S, Ayotte P. Thyroid function and plasma concentrations of polyhalogenated compounds in Inuit adults. Environ Health Perspect 2009; 117: 1380-1386.

Ghisari M, Bonefeld-Jorgensen EC. Impact of environmental chemicals on the thyroid hormone function in pituitary rat GH3 cells. Mol Cell Endocrinol 2005; 244: 31-41.




DOI: http://dx.doi.org/10.14800/rci.702

Refbacks

  • There are currently no refbacks.




Copyright (c) 2015 Christian Bjerregaard-Olesen, Eva Cecilie Bonefeld-Jørgensen

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.